Financial News
Aerovate Therapeutics Inc (NQ: AVTE )
1.870
+0.030
(+1.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Aerovate Therapeutics Inc
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics to Explore Strategic Alternatives
July 08, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
![](https://ml.globenewswire.com/media/5fe89d51-5e46-4a1e-945c-a257c81b0d95/small/aerovate-logo-horizontal-png.png)
Aerovate Therapeutics Announces Third Quarter 2022 Financial Results
November 14, 2022
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.